- Dec 31, 2020
HealthTree University Myeloma: What are the different catheters and ports?
HealthTree University Myeloma: What are the different catheters and ports? HealthTree University Myeloma: What are the different...
81
- Dec 31, 2020
Dana-Farber's 2020 Multiple Myeloma Patient Symposium - Current and Future Treatment of Myeloma
Watch on YouTube Current and Future Treatment of Multiple Myeloma Jan 19, 2021 Dana-Farber Cancer Institute https://www.dana-farber.org/m...
69
- Dec 30, 2020
NCT04688853: Phase 1 - A Study to Investigate the Safety and Efficacy of TEG002 in RRMM
NCT04688853: Phase 1 - A Study to Investigate the Safety and Efficacy of TEG002 in Relapsed/Refractory Multiple Myeloma Patients This is...
201
- Dec 29, 2020
NCT04634552: Phase 2 - A Study of Talquetamab in Participants With Refractory Multiple Myeloma
Talquetamab Phase 2 A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma A Study of Talquetamab in...
846
- Dec 27, 2020
NCT04674813: Phase 1 - A Study of CC-95266 in Subjects With Relapsed and/or Refractory Myeloma
A Study of CC-95266 in Subjects With Relapsed and/or Refractory Multiple Myeloma This is a Phase 1, multicenter, open label, study of...
275
- Dec 24, 2020
NCT04570631: Phase 1: Eftozanermin Alfa (ABBV-621) + Bortezomib and Oral Dexamethasone RRMM
NCT04570631: Phase 1: Study to Determine Recommended Phase 2 Dose of Intravenous (IV) Eftozanermin Alfa in Combination With IV or...
90